Commonwealth Equity Services LLC Has $45.59 Million Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Commonwealth Equity Services LLC lifted its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 2.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 76,704 shares of the biotechnology company’s stock after buying an additional 1,503 shares during the period. Commonwealth Equity Services LLC owned about 0.10% of Axon Enterprise worth $45,587,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Public Sector Pension Investment Board raised its holdings in shares of Axon Enterprise by 19.2% during the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after acquiring an additional 500 shares in the last quarter. CIBC Asset Management Inc raised its holdings in shares of Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after acquiring an additional 895 shares in the last quarter. Soros Capital Management LLC purchased a new stake in shares of Axon Enterprise during the third quarter worth $630,000. Friedenthal Financial raised its holdings in shares of Axon Enterprise by 961.7% during the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after acquiring an additional 1,231 shares in the last quarter. Finally, Principal Financial Group Inc. raised its holdings in shares of Axon Enterprise by 33.1% during the third quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock worth $54,466,000 after acquiring an additional 33,869 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Activity

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeffrey C. Kunins sold 1,370 shares of Axon Enterprise stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $639.14, for a total value of $875,621.80. Following the sale, the insider now directly owns 125,950 shares in the company, valued at approximately $80,499,683. This trade represents a 1.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 5,146 shares of company stock valued at $3,262,847. 6.10% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on AXON shares. TD Cowen started coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. The Goldman Sachs Group raised their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Craig Hallum lowered Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Finally, Needham & Company LLC restated a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a report on Wednesday, February 26th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $604.67.

Axon Enterprise Trading Up 4.1 %

Shares of NASDAQ:AXON opened at $556.26 on Friday. The company has a market cap of $42.62 billion, a P/E ratio of 143.74, a P/E/G ratio of 5.17 and a beta of 1.12. The stock’s 50-day moving average is $594.32 and its 200-day moving average is $532.91. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.